Hiperobesity v/s morbid obesity: A comparative study Hiperobesidad y obesidad mórbida: Estudio comparative
Author
dc.contributor.author
Lanzarini Sobrevia, Enrique
Author
dc.contributor.author
Marambio G., Andrés
Author
dc.contributor.author
Lara Fernández, R.
Author
dc.contributor.author
Lasnibat, José
Author
dc.contributor.author
Jans B., Jaime
Author
dc.contributor.author
Díaz G., Emma
Author
dc.contributor.author
Riffo Muñoz, Andrea
Author
dc.contributor.author
Papapietro Vallejo, Karin
Author
dc.contributor.author
Maher, Musleh K.
Author
dc.contributor.author
Díaz Jeraldo, Juan
Author
dc.contributor.author
Braghetto Miranda, Italo
Author
dc.contributor.author
Csendes Juhasz, Attila
Admission date
dc.date.accessioned
2019-03-11T13:03:59Z
Available date
dc.date.available
2019-03-11T13:03:59Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Revista Chilena de Cirugia, Volumen 64, Issue 3, 2018, Pages 233-237
Identifier
dc.identifier.issn
03793893
Identifier
dc.identifier.issn
07184026
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165577
Abstract
dc.description.abstract
Introduction: Bariatric surgery is effective and safe in treating obese patients with BMI > 40, however, higher preoperative weight could increases morbidity and mortality. Aim: To describe and compare the perioperative and mid term outcomes between hiperobese and morbidly obese patients submitted to gastric bypass. Material and Method: A prospective study of hiperobese patients submitted to gastric bypass over the past 10 years. We analyzed clinical characteristics, perioperative morbimortality and resolution of comorbidities. The results were compared with a group of morbidly obese patients matched by age and sex. Results: 146 hiperobese were operated and compared with 165 morbidly obese patients. 66.8% were female and the average age of the total group was 39.9 ± 12.4 years, with no significant differences between groups by sex and age. The average BMI was 53 and 44.4 respectively. 21.5% had diabetes mellitus 2, 39.5% hypertension, 31% dislipidemia and 8.4% osteoarthritis, with no s